Rita M. La Rovere
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.
Journal: Cell death & disease
Published: May 12, 2020
Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2.
Journal: Cell death and differentiation
Published: July 30, 2017
Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signaling.
Journal: Cell calcium
Published: April 28, 2017
IP3 Receptor Properties and Function at Membrane Contact Sites.
Journal: Advances in experimental medicine and biology
Published: January 01, 2017
Endoplasmic Reticulum-Mitochondrial Ca2+ Fluxes Underlying Cancer Cell Survival.
Journal: Frontiers in oncology
Published: December 12, 2016
Human periodontal ligament stem cells cultured onto cortico-cancellous scaffold drive bone regenerative process.
Journal: European cells & materials
Published: September 17, 2016
The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Journal: The Journal of biological chemistry
Published: October 29, 2014
Cellular and molecular responses of human skeletal muscle exposed to hypoxic environment.
Journal: Journal of biological regulators and homeostatic agents
Published: January 06, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026